Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Duke Capital
FY’24 results: record cashflows
12th Jul 2024
Apax Global Alpha
CM day: further proof of value added by Apax
10th Jul 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
99: Building a medical company without a specialist background | Clare Brenner of Myogenes
Stay up-to-date with the latest research
Sign up to our newsletter
Latest research
Our research can be accessed for free under MIFID.
Find out more >
All research
Corporate research
- Update
- Monthly Report
- Sector Report
Tax advantaged research
- VCT
- EIS
- SEIS
- Initiation
- BR Review
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
List companies
Chamberlin Plc
Industrial
Turbo-charging into a new growth phase
By
Paul Singer
21 Mar 2017
Avacta Group plc
Life Sciences
Low response would be positive!
21 Mar 2017
Burford Capital
Financials
Another positive verdict
By
Dr Brian Moretta
20 Mar 2017
Advanced Oncotherapy
Life Sciences
Delivery of LIGHT
By
Dr Martin Hall
15 Mar 2017
Non-Standard Finance
Financials
Branching Out Investment accelerated
By
Mark Thomas
13 Mar 2017
Tissue Regenix
Life Sciences
Addressing woundcare in the US
13 Mar 2017
Collagen Solutions Plc
Life Sciences
Engineering cartilage repairs
By
Dr Martin Hall
13 Mar 2017
Primary Health Properties
Property
Clear road, full tank, strong dividend prospects
By
Mike Foster
02 Mar 2017
R.E.A. Holdings
Agriculture
Trading Update 2016 Year
By
Yingheng Chen
22 Feb 2017
City of London Investment Group
Financials
H1 results confirm dividend cover
By
Dr Brian Moretta
20 Feb 2017
Collagen Solutions Plc
Life Sciences
Capital increase to support accelerated growth
By
Dr Martin Hall
14 Feb 2017
Prev
1
...
78
79
80
81
Next